160 related articles for article (PubMed ID: 37378020)
1. Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2- h sampling.
Liu X; Guo C; Bian J; Hao S; Lou Y; Zhang H; Zhou X; Cai J; Ma W
Front Endocrinol (Lausanne); 2023; 14():1183161. PubMed ID: 37378020
[TBL] [Abstract][Full Text] [Related]
2. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
3. [The Diagnostic Value of Captopril Challenge Test for Primary Aldosteronism].
Chen SH; Luo PY; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):134-141. PubMed ID: 33474903
[TBL] [Abstract][Full Text] [Related]
4. [Re-evaluation of the diagnostic value and optimal cutoff point of captopril challenge test in diagnosis of primary aldosteronism].
Luo Y; He WW; Cheng QF; Yang SM; Du ZP; Mei M; Xu ZX; Hu JB; Wang KR; He YF; Li QF; Song Y
Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):60-65. PubMed ID: 34979771
[No Abstract] [Full Text] [Related]
5. Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study.
Tezuka Y; Omata K; Ono Y; Kambara K; Kamada H; Oguro S; Yamazaki Y; Gomez-Sanchez CE; Ito A; Sasano H; Takase K; Tanaka T; Katagiri H; Satoh F
Hypertens Res; 2024 May; 47(5):1362-1371. PubMed ID: 38454147
[TBL] [Abstract][Full Text] [Related]
6. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism.
Meng X; Li Y; Wang X; Li J; Liu Y; Yu Y
J Clin Endocrinol Metab; 2018 Mar; 103(3):853-860. PubMed ID: 29300995
[TBL] [Abstract][Full Text] [Related]
8. Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study.
Liu B; Hu J; Song Y; He W; Cheng Q; Wang Z; Feng Z; Du Z; Xu Z; Yang J; Li Q; Yang S;
Endocr Pract; 2021 Apr; 27(4):326-333. PubMed ID: 33779561
[TBL] [Abstract][Full Text] [Related]
9. A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism.
Lin C; Yang J; Fuller PJ; Jing H; Song Y; He W; Du Z; Luo T; Cheng Q; Yang S; Wang H; Li Q; Hu J;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):131-137. PubMed ID: 31774187
[TBL] [Abstract][Full Text] [Related]
10. Comparison of saline infusion test and captopril challenge test in the diagnosis of Chinese with primary aldosteronism in different age groups.
Sun K; Gong M; Yu Y; Yang M; Zhang Y; Jiang Y; Song W
Front Endocrinol (Lausanne); 2024; 15():1343704. PubMed ID: 38586461
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
12. The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.
Kuo CC; Balakrishnan P; Hsein YC; Wu VC; Chueh SC; Chen YM; Wu KD; Wang MJ;
J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):587-98. PubMed ID: 25031295
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma.
Chen S; Liu H; Luo P; Yu Y
Endocr J; 2021 Mar; 68(3):299-306. PubMed ID: 33100281
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of Screening and Confirmatory Tests of Primary Aldosteronism in Diagnosing Aldosterone Producing Adenoma].
Hu FQ; Huang J; Huang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):469-473. PubMed ID: 30014653
[TBL] [Abstract][Full Text] [Related]
15. The Value of Different Single or Combined Indexes of the Captopril Challenge Test in the Diagnosis of Primary Aldosteronism.
Xiang Q; Chen T; Yu K; Li Y; Li Q; Tian H; Ren Y
Front Endocrinol (Lausanne); 2021; 12():689618. PubMed ID: 34220715
[TBL] [Abstract][Full Text] [Related]
16. Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism.
Kawashima J; Araki E; Naruse M; Kurihara I; Takahashi K; Tamura K; Kobayashi H; Okamura S; Miyauchi S; Yamamoto K; Izawa S; Suzuki T; Tanabe A
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32157288
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
[TBL] [Abstract][Full Text] [Related]
18. Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism.
Wada N; Miyoshi A; Usubuchi H; Terae S; Shibayama Y; Takahashi B; Baba S; Sugawara H; Obara S
Endocr J; 2021 Jan; 68(1):45-51. PubMed ID: 32848105
[TBL] [Abstract][Full Text] [Related]
19. Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.
Song Y; Yang S; He W; Hu J; Cheng Q; Wang Y; Luo T; Ma L; Zhen Q; Zhang S; Mei M; Wang Z; Qing H; Bruemmer D; Peng B; Li Q;
Hypertension; 2018 Jan; 71(1):118-124. PubMed ID: 29158354
[TBL] [Abstract][Full Text] [Related]
20. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
Hu Y; Zhang J; Liu W; Su X
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32163576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
